ASPN Form 3: Grant Thoele discloses shares and options
Rhea-AI Filing Summary
Aspen Aerogels reporting person Grant Thoele filed an initial Form 3 disclosing his beneficial ownership in ASPN. He directly holds 4,608 shares of common stock and holds multiple stock option grants exercisable between 11/02/2031 and 03/05/2035 covering a total of several thousand shares at exercise prices from $7.84 to $52.60. He also holds 12,755 performance share units that vest after a performance period ending 12/31/2027 and pay out based on relative total shareholder return versus the Russell 2000.
Positive
- None.
Negative
- None.
Insider Trade Summary
8 transactions reported
Mixed
8 txns
Insider
Thoele Grant Douglas
Role
CFO & Treasurer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Performance Share Units | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Options (Right to Buy) — 27,444 shares (Direct);
Performance Share Units — 12,755 shares (Direct);
Common Stock — 4,608 shares (Direct)
Footnotes (6)
- F1. These options to purchase shares of our common stock were granted on November 2, 2021 and vested as to one-third of the shares on each anniversary of the grant date until November 2, 2024.
- F2. These options to purchase shares of our common stock were granted on February 23, 2022 and vested as to one-third of the shares on each anniversary of the grant date until February 23, 2025.
- F3. These options to purchase shares of our common stock were granted on March 8, 2023 and vested as to one-third of the shares on each anniversary of the grant date until March 8, 2026.
- F4. These options to purchase shares of our common stock were granted on March 5, 2024 and vested as to one-third of the shares on each anniversary of the grant date until March 5, 2027.
- F5. These options to purchase shares of our common stock were granted on March 5, 2025 and vested as to one-third of the shares on each anniversary of the grant date until March 5, 2028.
- F6. Each performance share unit ("PSU") represents a contingent right to receive one share of Common Stock upon vesting. The PSUs vest on March 5, 2028, following the completion of the performance period, which begins on January 1, 2025 and ends on December 31, 2027. Ranging between 0-200% of the target number of PSUs (as reflected in Table II above), the PSUs vest based on the total shareholder return of Common Stock relative to the total stockholder return of the components of the Russell 2000 Index.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did the Form 3 filed for Aspen Aerogels (ASPN) disclose?
The Form 3 discloses that reporting person Grant Thoele directly owns 4,608 shares, holds multiple stock options exercisable from 11/02/2031 through 03/05/2035, and 12,755 performance share units.
What are the exercise prices and ranges for the stock options reported on ASPN Form 3?
The disclosed stock options have exercise prices ranging from $7.84 to $52.60.
Who signed the Form 3 filing for Grant Thoele and when was it filed?
The Form 3 is signed by an attorney-in-fact, Glenn Deegan, and dated 10/02/2025; the event date on the form is 10/01/2025.